What AI Companies Get Wrong About Curing Cancer (with Emilia Javorsky)

The podcast explores the oversimplified promise that AI will cure cancer, dissecting the complexities of applying AI to a disease as multifaceted as cancer. Physician and scientist Emilia Javorsky argues that intelligence isn't the primary bottleneck; issues lie in data accessibility, incentives, and coordination. She highlights the lack of standardized, accessible biological data for AI training, contrasting it with the Protein Data Bank's success with AlphaFold. Javorsky points out that cancer isn't a single disease but an evolutionary shadow, with each species developing cancer resilience through distinct genetic pathways. She suggests focusing on AI tools to reduce friction in drug development, restructuring incentives, and creating large-scale datasets to accelerate progress in cancer research.